Distribution of Tumor-Infiltrating Immune Cells in Glioblastoma
Enrique Orrego(Instituto Nacional de Enfermedades Neoplásicas), Luis Pacheco Ojeda(Hospital Metropolitano), Carolina Belmar-López(Instituto Nacional de Enfermedades Neoplásicas), Carlos A. Castañeda(Instituto Nacional de Enfermedades Neoplásicas), Ómar Mejìa(Instituto Nacional de Enfermedades Neoplásicas), Miluska Castillo(Instituto Nacional de Enfermedades Neoplásicas), Maria R Villa-Robles(Instituto Nacional de Enfermedades Neoplásicas), Pedro Deza(Instituto Nacional de Enfermedades Neoplásicas), Sandro Casavilca‐Zambrano(Institute for Anthropological Research), Rocio Zevallos(Instituto Nacional de Enfermedades Neoplásicas), Pamela García-Corrochano(Instituto Nacional de Enfermedades Neoplásicas), Luis A. Bernabe(Instituto Nacional de Enfermedades Neoplásicas), Wei Meng(Ministry of Education of the People's Republic of China), Arnab Chakravarti(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute)
Cited by 67
Related Papers
Glucose-Mediated N-glycosylation of SCAP Is Essential for SREBP-1 Activation and Tumor Growth
|Cancer Cell|2015|336
Inhibition of SOAT1 Suppresses Glioblastoma Growth via Blocking SREBP-1–Mediated Lipogenesis
|Clinical Cancer Research|2016|332
The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group
|npj Breast Cancer|2021|282
Malignant Gliomas with Primitive Neuroectodermal Tumor‐like Components: A Clinicopathologic and Genetic Study of 53 Cases
|Brain Pathology|2008|178
The phosphatidyl inositol 3-kinase/AKT signaling pathway in breast cancer
|Cancer and Metastasis Reviews|2010|171